Omada Health, Inc. Cost of Revenue
Omada Health, Inc. (OMDA) reported Cost of Revenue of $24.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-07
- Omada Health, Inc. cost of revenue for the quarter ending 2026-06-30 was $24.05M, a 14.16% increase year-over-year.
- Omada Health, Inc. cost of revenue for the quarter ending 2026-03-31 was $29.36M, a 27.28% increase year-over-year.
- Omada Health, Inc. cost of revenue for the quarter ending 2025-12-31 was $22.18M, a 40.01% increase year-over-year.
- Omada Health, Inc. cost of revenue for the quarter ending 2025-09-30 was $22.96M, a 35.43% increase year-over-year.
- Omada Health, Inc. cost of revenue for fiscal 2025 was $89.27M, a 33.39% increase from fiscal 2024.
- Omada Health, Inc. cost of revenue for fiscal 2024 was $66.92M, a 26.72% increase from fiscal 2023.
- Omada Health, Inc. cost of revenue for fiscal 2023 was $52.81M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $24.05M 10-Q · filed 2026-08-07 | $53.40M 10-Q · filed 2026-08-07 | $75.59M derived: sum of 3 quarters · filed 2026-08-07 | $98.55M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $29.36M 10-Q · filed 2026-05-08 | $51.54M derived: sum of 2 quarters · filed 2026-05-08 | $74.50M derived: sum of 3 quarters · filed 2026-05-08 | $95.56M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $22.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $45.14M derived: sum of 2 quarters · filed 2026-03-06 | $66.21M derived: sum of 3 quarters · filed 2026-08-07 | $89.27M 10-K · filed 2026-03-06 |
| 2025-09-30 | $22.96M 10-Q · filed 2025-11-07 | $44.02M derived: sum of 2 quarters · filed 2026-08-07 | $67.09M 10-Q · filed 2025-11-07 | $82.93M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $21.07M 10-Q · filed 2026-08-07 | $44.13M 10-Q · filed 2026-08-07 | $59.97M derived: sum of 3 quarters · filed 2026-08-07 | $76.93M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $23.06M 10-Q · filed 2026-05-08 | $38.91M derived: sum of 2 quarters · filed 2026-05-08 | $55.86M derived: sum of 3 quarters · filed 2026-05-08 | $72.24M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $15.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $32.80M derived: sum of 2 quarters · filed 2026-03-06 | $49.18M derived: sum of 3 quarters · filed 2026-03-06 | $66.92M 10-K · filed 2026-03-06 |
| 2024-09-30 | $16.95M 10-Q · filed 2025-11-07 | $33.33M derived: sum of 2 quarters · filed 2025-11-07 | $51.08M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $16.38M 10-Q · filed 2025-08-08 | $34.13M 10-Q · filed 2025-08-08 | ||
| 2023-12-31 | $52.81M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |